Table 3 Association of mRNA expression of target genes with clinicopathological features in polyps.
mRNA expression | Parameters | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Size | Dysplasia | Location | ||||||||
Genes | RQ# | < 10 mm | ≥ 10 mm | P-value | High-grade | Low-grade | P- value | Proximal | Distal | P-value |
CDC42 | < 1 | 66.7% | 27.3% | 0.17 | 11.1% | 60.7% | 0.010* | 24.3% | 66.7% | 0.017* |
> 1 | 33.3% | 72.7% | 88.9% | 39.3% | 75.7% | 33.3% | ||||
TAGLN | < 1 | 55.6% | 18.2% | 0.16 | 11.1% | 54.5% | 0.03* | 27.3% | 44.4% | 0.64 |
> 1 | 44.4% | 81.8% | 88.9% | 45.5% | 72.7% | 55.6% | ||||
GSN | < 1 | 44.4% | 36.4% | 0.99 | 33.3% | 45.5% | 0.67 | 36.4% | 44.4% | 1.00 |
> 1 | 55.6% | 63.6% | 66.7% | 54.5% | 63.6% | 55.6% | ||||
